IDEAS logo
Project spotlight:

12. Statistical methods for phase I/II trials of molecularly targeted agents in oncology

Conventional dose-finding approaches mainly consider severe toxicities observed during the first cycle. This may not be relevant for molecularly targeted agents usually administered in chronic schedules, and for which more than 50% of severe toxicities occurred after the first cycle.

[ see all projects ]